Cart
sales@molnova.com
Potassium iodide
CAS No. 7681-11-0
Potassium iodide( —— )
Catalog No. M15904 CAS No. 7681-11-0
Potassium iodide is used to treat overactive thyroid and to protect the thyroid gland from the effects of radiation from inhaled or swallowed radioactive iodine.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 62 | In Stock |
|
| 25MG | 218 | In Stock |
|
| 50MG | 301 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePotassium iodide
-
NoteResearch use only, not for human use.
-
Brief DescriptionPotassium iodide is used to treat overactive thyroid and to protect the thyroid gland from the effects of radiation from inhaled or swallowed radioactive iodine.
-
DescriptionPotassium iodide is used to treat overactive thyroid and to protect the thyroid gland from the effects of radiation from inhaled or swallowed radioactive iodine. It may be used before and after administration of medicine containing radioactive iodine or after accidental exposure to radioactive iodine.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetTyrosinase
-
RecptorTyrosinase
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number7681-11-0
-
Formula Weight166.01
-
Molecular Formula——
-
Purity>98% (HPLC)
-
SolubilityWater: 33 mg/mL (198.79 mM); DMSO: 33 mg/mL (198.79 mM)
-
SMILES[K+].[I-]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Pisarev MA, Aiello LO. Acta Endocrinol (Copenh). 1976 Jun;82(2):298-305.
molnova catalog
related products
-
Licraside
Licraside is a tyrosinase inhibitor with an IC50 of 0.072 mM for monophenolase and can be used in studies about antibrowning and depigmenting agents.
-
Ropsacitinib
Ropsacitinib (PF-06826647) is a selective TYK2 inhibitor, which binds to TYK2 catalytically active JH1 domain (IC50: 17 nM).
-
(Z)-SU14813
(Z)-SU14813 is a novel tyrosine kinase inhibitor with anticardiogenic and antitumor activity that inhibits VEGFR-2, PDGFR-β, and FLT3 phosphorylation in xenograft tumors in a dose- and time-dependent manner.
